David Turkaly
Stock Analyst at JMP Securities
(2.17)
# 2,869
Out of 4,966 analysts
139
Total ratings
39.37%
Success rate
-3.91%
Average return
Main Sectors:
Stocks Rated by David Turkaly
| Stock | Action | Price Target | Current | Upside | Ratings | Updated | |
|---|---|---|---|---|---|---|---|
| KIDS OrthoPediatrics | Maintains: Market Outperform | $50 → $35 | $21.36 | +63.86% | 11 | Aug 8, 2025 | |
| LNTH Lantheus Holdings | Maintains: Market Outperform | $112 → $73 | $54.90 | +32.97% | 9 | Aug 7, 2025 | |
| OFIX Orthofix Medical | Reiterates: Market Perform | n/a | $14.98 | - | 2 | Jun 6, 2025 | |
| GMED Globus Medical | Reiterates: Market Perform | n/a | $61.27 | - | 3 | May 27, 2025 | |
| HAE Haemonetics | Reiterates: Market Outperform | $100 | $54.54 | +83.35% | 12 | May 20, 2025 | |
| STE STERIS | Maintains: Market Outperform | $265 → $280 | $245.06 | +14.26% | 18 | May 16, 2025 | |
| IART Integra LifeSciences Holdings | Maintains: Market Outperform | $35 → $25 | $15.13 | +65.23% | 15 | May 9, 2025 | |
| ENOV Enovis | Maintains: Market Outperform | $62 → $55 | $30.90 | +77.99% | 2 | May 9, 2025 | |
| ZBH Zimmer Biomet Holdings | Maintains: Market Outperform | $140 → $125 | $106.10 | +17.81% | 14 | May 7, 2025 | |
| CRWD CrowdStrike Holdings | Maintains: Market Outperform | $400 → $500 | $423.70 | +18.01% | 1 | May 5, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterates: Market Perform | n/a | $391.41 | - | 3 | May 5, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterates: Market Perform | n/a | $126.41 | - | 15 | Apr 2, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Market Outperform | $12 → $7 | $1.78 | +293.26% | 6 | Mar 21, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterates: Market Outperform | $26 | $16.14 | +61.09% | 7 | Mar 5, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterates: Market Outperform | $32 | $16.67 | +91.96% | 7 | Feb 25, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterates: Market Outperform | $16 | $7.14 | +124.09% | 1 | Jan 29, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterates: Market Perform | n/a | $1.99 | - | 5 | Sep 16, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Market Outperform | $7 → $3 | $3.33 | -9.91% | 7 | Aug 14, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Outperform | $5 | $8.93 | -44.01% | 1 | Oct 6, 2017 |
OrthoPediatrics
Aug 8, 2025
Maintains: Market Outperform
Price Target: $50 → $35
Current: $21.36
Upside: +63.86%
Lantheus Holdings
Aug 7, 2025
Maintains: Market Outperform
Price Target: $112 → $73
Current: $54.90
Upside: +32.97%
Orthofix Medical
Jun 6, 2025
Reiterates: Market Perform
Price Target: n/a
Current: $14.98
Upside: -
Globus Medical
May 27, 2025
Reiterates: Market Perform
Price Target: n/a
Current: $61.27
Upside: -
Haemonetics
May 20, 2025
Reiterates: Market Outperform
Price Target: $100
Current: $54.54
Upside: +83.35%
STERIS
May 16, 2025
Maintains: Market Outperform
Price Target: $265 → $280
Current: $245.06
Upside: +14.26%
Integra LifeSciences Holdings
May 9, 2025
Maintains: Market Outperform
Price Target: $35 → $25
Current: $15.13
Upside: +65.23%
Enovis
May 9, 2025
Maintains: Market Outperform
Price Target: $62 → $55
Current: $30.90
Upside: +77.99%
Zimmer Biomet Holdings
May 7, 2025
Maintains: Market Outperform
Price Target: $140 → $125
Current: $106.10
Upside: +17.81%
CrowdStrike Holdings
May 5, 2025
Maintains: Market Outperform
Price Target: $400 → $500
Current: $423.70
Upside: +18.01%
May 5, 2025
Reiterates: Market Perform
Price Target: n/a
Current: $391.41
Upside: -
Apr 2, 2025
Reiterates: Market Perform
Price Target: n/a
Current: $126.41
Upside: -
Mar 21, 2025
Maintains: Market Outperform
Price Target: $12 → $7
Current: $1.78
Upside: +293.26%
Mar 5, 2025
Reiterates: Market Outperform
Price Target: $26
Current: $16.14
Upside: +61.09%
Feb 25, 2025
Reiterates: Market Outperform
Price Target: $32
Current: $16.67
Upside: +91.96%
Jan 29, 2025
Reiterates: Market Outperform
Price Target: $16
Current: $7.14
Upside: +124.09%
Sep 16, 2024
Reiterates: Market Perform
Price Target: n/a
Current: $1.99
Upside: -
Aug 14, 2024
Maintains: Market Outperform
Price Target: $7 → $3
Current: $3.33
Upside: -9.91%
Oct 6, 2017
Initiates: Outperform
Price Target: $5
Current: $8.93
Upside: -44.01%